GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (OTCPK:HNSPF) » Definitions » Additional Paid-In Capital

Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Additional Paid-In Capital : $1,974 Mil(As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Additional Paid-In Capital?


Hansoh Pharmaceutical Group Co's quarterly additional paid-in capital declined from Dec. 2022 ($1,998 Mil) to Jun. 2023 ($1,968 Mil) but then increased from Jun. 2023 ($1,968 Mil) to Dec. 2023 ($1,974 Mil).

Hansoh Pharmaceutical Group Co's annual additional paid-in capital increased from Dec. 2021 ($0 Mil) to Dec. 2022 ($1,998 Mil) but then declined from Dec. 2022 ($1,998 Mil) to Dec. 2023 ($1,974 Mil).


Hansoh Pharmaceutical Group Co Additional Paid-In Capital Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Additional Paid-In Capital Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial - - - 1,998.30 1,974.11

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1,998.30 1,968.26 1,974.11

Hansoh Pharmaceutical Group Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Hansoh Pharmaceutical Group Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hansoh Pharmaceutical Group Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.

Hansoh Pharmaceutical Group Co (Hansoh Pharmaceutical Group Co) Headlines

No Headlines